Agencia EFEApril 29, 2013 15:16
London, Apr 29 (EFE).- The European Medicines Agency on Monday recommended suspending the marketing of medicines containing tetrazepam in the European Union's 27 member-states due to possible adverse effects on the skin.
Tetrazepam, whose best-known brand name is Myolastan, is used above all as a muscle relaxant and for sharp pains from cramps, particularly in the back and neck, but undesirable skin reactions have now been detected.
Follow us: